Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 348 entries
View as:

Compassionate Use of REGN-COV2 for the Treatment of COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04617535 Org: User:
Start: - End: - Due: -

Ascending Dose Study of the Safety and Tolerability of REGN728 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01197391 Org: User:
Start: 08/31/10 End: 03/31/12 Due: 03/31/13

Long Term Safety Study of PRALUENT

Phase: N/A Priority: Normal
NCT ID: NCT03694197 Org: User:
Start: 09/28/18 End: 04/08/20 Due: 04/08/21

An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1)

Phase: N/A Priority: Normal
NCT ID: NCT03002376 Org: User:
Start: 04/10/17 End: 03/19/20 Due: 03/19/21

Ascending Dose Study of the Safety and Tolerability of REGN727(SAR236553) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01026597 Org: User:
Start: 11/30/09 End: 10/31/10 Due: 10/31/11

Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)

Phase: N/A Priority: Normal
NCT ID: NCT03428646 Org: User:
Start: 04/06/18 End: 03/30/27 Due: 03/30/28

Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT01363440 Org: User:
Start: 05/31/11 End: 11/30/14 Due: 11/30/15

A Compassionate Use (CU) Program of Odronextamab

Phase: N/A Priority: Normal
NCT ID: NCT05619367 Org: User:
Start: - End: - Due: -

Single Ascending-dose Study of the Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01922661 Org: User:
Start: 08/31/13 End: 05/31/14 Due: 05/31/15

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN9933 in Adult Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05102136 Org: User:
Start: 10/27/21 End: 04/04/23 Due: 04/04/24

Study to Assess the Safety and Tolerability of Single Doses of REGN1500

Phase: N/A Priority: Normal
NCT ID: NCT01749878 Org: User:
Start: 12/31/12 End: 01/31/16 Due: 01/31/17

Dose Escalation Study With Bispecific Antibodies in Adult Patients With Lupus Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT06975787 Org: User:
Start: 11/08/25 End: 10/10/28 Due: 10/10/29

A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

Phase: N/A Priority: Normal
NCT ID: NCT05070858 Org: User:
Start: 12/14/21 End: 03/18/29 Due: 03/18/30

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Non-Alcoholic Fatty Liver Disease (NAFLD)

Phase: N/A Priority: Normal
NCT ID: NCT05648214 Org: User:
Start: 12/27/22 End: 10/18/25 Due: 10/18/26

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06787612 Org: User:
Start: 05/28/25 End: 12/07/28 Due: 12/07/29

Single Injection of REGN475/SAR164877 in Treatment of Vertebral Fracture Pain

Phase: N/A Priority: Normal
NCT ID: NCT01001715 Org: User:
Start: 11/30/09 End: 01/31/11 Due: 01/31/12

A Study to Examine the Safety and Tolerability of Single Ascending Doses of REGN2477

Phase: N/A Priority: Normal
NCT ID: NCT02870400 Org: User:
Start: 07/31/16 End: 01/12/17 Due: 01/12/18

A Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva

Phase: N/A Priority: Normal
NCT ID: NCT03188666 Org: User:
Start: 02/26/18 End: 09/16/21 Due: 09/16/22

Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy

Phase: N/A Priority: Normal
NCT ID: NCT03793608 Org: User:
Start: 03/12/19 End: 05/12/21 Due: 05/12/22

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Phase: N/A Priority: Normal
NCT ID: NCT05519475 Org: User:
Start: 02/09/23 End: 09/08/27 Due: 09/08/28

A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06161441 Org: User:
Start: 07/16/24 End: 04/19/29 Due: 04/19/30

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

Phase: N/A Priority: Normal
NCT ID: NCT05137054 Org: User:
Start: 08/17/22 End: 09/26/34 Due: 09/26/35

Study Evaluating CMP-001 in Combination With Atezolizumab in Participants With Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03438318 Org: User:
Start: 03/15/18 End: 12/11/19 Due: 12/11/20

A Trial to Learn if Different Doses of REGN7544 Are Safe in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05970718 Org: User:
Start: 08/07/23 End: 07/22/24 Due: 07/22/25

A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have

Phase: N/A Priority: Normal
NCT ID: NCT05831176 Org: User:
Start: 05/03/23 End: 03/24/27 Due: 03/24/28